1. Chlebowski R. T., Hendrix S. L., Langer R. D., et al. WHI Investigators. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial // Journal of the American Medical Association. – 2003. – Vol. 289. – P. 3243–3253.
2. Sjögren L. L., Mørch L. S., Løkkegaard E. Hormone replacement therapy and the risk of endometrial cancer: A systematic review // Maturitas. – 2016. – Vol. 91. – P. 25–35.
3. Sweetland S., Beral V., Balkwill A., et al. Venous thromboembolism risk in relation to use of different types of postmenopausal hormone therapy in a large prospective study // Journal of Thrombosis and Haemostasis. – 2012. – Vol. 10. – P. 2277–2286.
4. Зайдиева Я. З. Альтернативная терапия менопаузальных расстройств у женщин в климактерии // Русский Медицинский Журнал. Мать и дитя. – 2017. – Т. 25. – № 12. –С. 873–878.
5. Кузнецова И. В. Фитоэстрогены в лечении климактерических расстройств // Гинекология. – 2012. – Т. 14. – № 6. – С. 20–23.
6. Сметник В. П. Селективные эстроген-рецепторные модуляторы – альтернатива заместительной гормонотерапии. Руководство по остеопорозу / под ред. Л. И. Беневоленской. – М. : Бином. – 2003. – C. 236–244.
7. Beck V., Rohr U., Jungbauer A. Phytoestrogens derived from red clover: An alternative to estrogen replacement therapy? // The Journal of Steroid Biochemistry and Molecular Biology. – 2005. – Vol. 94 (5). – P. 499–518. Doi: http://doi.org/10.1016/j.jsbmb. 2004.12.038).
8. Oseni T., Patel R., Pyle J., Jordan V. C. Selective estrogen receptor modulators and phytoestrogens // Planta Med. – 2008. – Vol. 74. – № 13. – P. 1656–1665.
9. Lipovac M., Chedraui P., Gruenhut C., Gocan A. The effect of red clover isoflavone supplementation over vasomotor and menopausal symptoms in postmenopausal women // Gynecological Endocrinology. – 2011. – Vol. 28 (3). – P. 203–207.
10. Myers S., Vigar V. Effects of a Standardised Extract of Trifolium pratense (Promensil) at a dosage of 80 mg in the treatment of menopausal hot flushes: A systematic review and meta-analysis. Phytomedicine. 24 10.1016/j.phymed.2016.12.003.
11. Nestel P. J., Pomeroy S., Kay S., et al. Isoflavones from red clover improve systemic arterial compliance but not plasma lipids in menopausal women // Journal of Clinical Endocrinology & Metabolism. – 1999. – Vol. 84(3). – P. 895–898.
12. Howes J. B., et al. Effects of dietary supplementation with isoflavones from red clover on ambulatory blood pressure and endothelial function in postmenopausal type 2 diabetes // Diabetes, Obesity and Metabolism . – 2003. – Vol. 5 (5). – P. 325–32.
13. Chedraui P., et al. Effect of Trifolium pratense-derived isoflavones on the lipid profile of postmenopausal women with increased body mass index // Gynecological Endocrinology. – 2008. – Vol. 24 (11). – P. 620–624.
14. Lipovac M., Gruenhut C., et al. Improvement of postmenopausal depressive and anxiety symptoms after treatment with isoflavones derived from red clover extracts // Maturitas. – 2010. – Vol. 65 (3). – P. 258–261.
15. Cegiela U., Folwarczna J., Zgórka G., et al. Effects of Extracts from Trifolium medium L. and Trifolium pratense L. on Development of Estrogen Deficiency-Induced Osteoporosis in Rats // Evidence-Based Complementary and Alternative Medicine. – 2012. Article ID 921684.
https://doi.org/10.1155/2012/921684.
16. Kaczmarczyk-Sedlak I., et al Effect of formononetin on mechanical properties and chemical composition of bones in rats with ovariectomy-induced osteoporosis // Evidence-based Complementary and Alternative Medicine. 2013 (2).
https://doi.org/10.1155/2013/457052